Authors : Xu Z; Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599-7360, USA.; Mansour HM

Subjects: Androstadienes/Androstadienes/Androstadienes/*chemistry ; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*chemistry ; Ipratropium/Ipratropium/Ipratropium/*chemistry

Source: Journal of pharmaceutical sciences [J Pharm Sci] 2010 Aug; Vol. 99 (8), pp. 3415-29.Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print Cited Medium: Internet ISSN: 1520-6017

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Pharmacokinetic and pharmacodynamic evaluation of the suitability of using fluticasone and an acute rat lung inflammation model to differentiate lung versus systemic efficacy.

Authors : Chiang PC; Global Research and Development, Pharmaceutical Research and Development, St. Louis Laboratories, Pfizer Inc., 700 Chesterfield Parkway N. T2F, Chesterfield, Missouri, USA. ; Hu Y

Subjects: Androstadienes/Androstadienes/Androstadienes/*pharmacokinetics ; Androstadienes/Androstadienes/Androstadienes/*pharmacology ; Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*pharmacokinetics

Source: Journal of pharmaceutical sciences [J Pharm Sci] 2009 Nov; Vol. 98 (11), pp. 4354-64.Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print Cited Medium: Internet ISSN: 1520-6017

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Pharmacokinetic and Pharmacodynamic Evaluation of the Suitability of Using Fluticasone and an Acute Rat Lung Inflammation Model to Differentiate Lung Versus Systemic Efficacy

Authors : Larry E. Kahn; Archie Thurston; Po-Chang Chiang

Subjects: Lipopolysaccharides; Male; Metabolic Clearance Rate

Source: Journal of Pharmaceutical Sciences. 98:4354-4364

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 2. Ipratropium bromide monohydrate and fluticasone propionate.

Authors : Zhen Xu¹; Mansour, Heidi M.²; Mulder, Tako³

Subjects: *AEROSOLS; *LACTOSE; *IPRATROPIUM (Drug)

Source: Journal of Pharmaceutical Sciences. Aug2010, Vol. 99 Issue 8, p3415-3429. 15p. 2 Black and White Photographs, 1 Diagram, 3 Charts, 6 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Dry Powder Aerosols Generated by Standardized Entrainment Tubes From Drug Blends With Lactose Monohydrate: 2. Ipratropium Bromide Monohydrate and Fluticasone Propionate

Authors : Tako Mulder; John Langridge; Richard McLean

Subjects: Drug Compounding; Analytical chemistry; Pharmaceutical Science

Source: Journal of Pharmaceutical Sciences. 99:3415-3429

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Dry Powder Formulations for Inhalation of Fluticasone Propionate and Salmeterol Xinafoate Microcrystals

Authors : Christopher Marriott; Darragh Murnane; Gary P. Martin

Subjects: Chemistry, Pharmaceutical; Drug Compounding; Pharmaceutical Science

Source: Journal of Pharmaceutical Sciences. 98:503-515

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Combination particles containing salmeterol xinafoate and fluticasone propionate: Formulation and aerodynamic assessment.

Dry powder formulations for inhalation of fluticasone propionate and salmeterol xinafoate microcrystals.

Pharmacokinetic and pharmacodynamic evaluation of the suitability of using fluticasone and an acute rat lung inflammation model to differentiate lung versus systemic efficacy.

Fluticasone and budesonide nanosuspensions for pulmonary delivery: Preparation, characterization, and pharmacokinetic studies.

Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 2. Ipratropium bromide monohydrate and fluticasone propionate.

Pharmacokinetic and pharmacodynamic evaluation of the suitability of using fluticasone and an acute rat lung inflammation model to differentiate lung versus systemic efficacy.

Pharmacokinetic and Pharmacodynamic Evaluation of the Suitability of Using Fluticasone and an Acute Rat Lung Inflammation Model to Differentiate Lung Versus Systemic Efficacy

Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 2. Ipratropium bromide monohydrate and fluticasone propionate.

Dry Powder Aerosols Generated by Standardized Entrainment Tubes From Drug Blends With Lactose Monohydrate: 2. Ipratropium Bromide Monohydrate and Fluticasone Propionate

Dry Powder Formulations for Inhalation of Fluticasone Propionate and Salmeterol Xinafoate Microcrystals

اتصل بنا

اتبع